Literature DB >> 17378848

Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor.

Mohamed A Taha1, Ahmed A Shokeir, Hussein G Osman, Abd El-Aziz F Abd El-Aziz, Sami E Farahat.   

Abstract

OBJECTIVES: To investigate the role of transforming growth factor beta(1) (TGF-beta(1)) and epidermal growth factor (EGF) in voided urine for the diagnosis and follow-up of children with pelvi-ureteric junction obstruction (PUJO). PATIENTS, SUBJECTS AND METHODS: The study included 35 children with unilateral PUJO who had a pyeloplasty, and 30 healthy control children. Urine samples were obtained from the bladders of patients before surgery, and as voided samples at 1, 2, 3, 6, 9 and 12 months after surgery. Bladder urine samples were also collected from all 30 children in the control group. TGF-beta(1) and EGF were then measured in all the urine samples.
RESULTS: The level of bladder TGF-beta(1) before surgery in the patients was significantly higher than that in the healthy control group. A threshold of 190 pg/mg creatinine gave a sensitivity of 100%, a specificity of 80%, a positive predictive value of 85.4%, negative predictive value of 100% and an overall accuracy of 90.8%. Compared with the value before surgery, urinary TGF-beta(1) was significantly lower at 1 year after pyeloplasty. There was no significant difference between the level of EGF before surgery in the patients and that in the control group, and no significant difference in the level of EGF before and after surgery over the follow-up.
CONCLUSION: We do not recommend using EGF levels in voided urine in the routine diagnosis of children with hydronephrosis. The urinary level of TGF-beta(1) is a useful noninvasive tool for the long-term follow-up of children with PUJO treated by pyeloplasty. Further studies with various controls are required to confirm the diagnostic accuracy of TGF-beta(1) in children with PUJO.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17378848     DOI: 10.1111/j.1464-410X.2006.06641.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  19 in total

1.  Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF.

Authors:  Zhenzhen Li; Zhanzheng Zhao; Xianghua Liu; Zhiqiang Su; Xiaoping Shang; Jianguo Wen
Journal:  Pediatr Nephrol       Date:  2012-07-08       Impact factor: 3.714

Review 2.  Urinary biomarkers for renal tract malformations.

Authors:  Pedro Magalhães; Joost P Schanstra; Emma Carrick; Harald Mischak; Petra Zürbig
Journal:  Expert Rev Proteomics       Date:  2016-11-15       Impact factor: 3.940

Review 3.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

4.  First-year profile of biomarkers for early detection of renal injury in infants with congenital urinary tract obstruction.

Authors:  Dusan Kostic; Glenda Priscila Neves Dos Santos Beozzo; Saulo Brasil do Couto; André Henrique Teruaki Kato; Laila Lima; Patricia Palmeira; Vera Lúcia Jornada Krebs; Victor Bunduki; Rossana Pulcineli Vieira Francisco; Marcelo Zugaib; Werther Brunow de Carvalho; Vera Hermina Kalika Koch
Journal:  Pediatr Nephrol       Date:  2019-01-29       Impact factor: 3.714

5.  Urinary proteome analysis identifies infants but not older children requiring pyeloplasty.

Authors:  Jens Drube; Petra Zürbig; Eric Schiffer; Esther Lau; Benno Ure; Sylvia Glüer; Martin Kirschstein; Lars Pape; Stéphane Decramer; Jean-Loup Bascands; Joost P Schanstra; Harald Mischak; Jochen H H Ehrich
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

6.  The role of urinary TGF-β₁, TNF-α, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves.

Authors:  Ankur Mandelia; Minu Bajpai; Sandeep Agarwala; Arun K Gupta; Rakesh Kumar; Abid Ali
Journal:  Pediatr Nephrol       Date:  2013-06-08       Impact factor: 3.714

7.  Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies.

Authors:  Mariana A Vasconcelos; Maria Candida F Bouzada; Katia D Silveira; Leticia R Moura; Fabiana F Santos; Juliana M Oliveira; Flavia F Carvalho; Mauro M Teixeira; Ana Cristina Simões E Silva; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2011-02-18       Impact factor: 3.714

Review 8.  Congenital urinary tract obstruction: the long view.

Authors:  Robert L Chevalier
Journal:  Adv Chronic Kidney Dis       Date:  2015-07       Impact factor: 3.620

9.  Non-invasive markers of ureteropelvic junction obstruction.

Authors:  Stephane Decramer; Jean-Loup Bascands; Joost P Schanstra
Journal:  World J Urol       Date:  2007-08-14       Impact factor: 4.226

Review 10.  Prognostic factors and biomarkers of congenital obstructive nephropathy.

Authors:  Robert L Chevalier
Journal:  Pediatr Nephrol       Date:  2015-12-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.